Advanced Tissue Sciences: Difference between revisions
m adjust REF... parameters |
m USSC, pages |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | <!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | ||
'''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested | '''Advanced Tissue Sciences''' is a corporation based in La Jolla, {{USSC|CA}}. They are the makers of [[Dermagraft-TC]], which is an artifical [[skin]] created from harvested [[foreskin]]s from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb | ||
| quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Advanced Biohealing, Inc. | |publisher=Advanced Biohealing, Inc. | ||
| | |date= | ||
| title=Dermagraft-TC: Overview | |title=Dermagraft-TC: Overview | ||
| url=http://www.dermagraft.com/about/overview/ | |url=http://www.dermagraft.com/about/overview/ | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{ REFweb | }}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{REFweb | ||
| quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin... | |quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin... | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Acroposthion.com | |publisher=Acroposthion.com | ||
| | |date= | ||
| title=The Foreskin Mafia | |title=The Foreskin Mafia | ||
| url=http://www.acroposthion.com/acroposthion_019.htm | |url=http://www.acroposthion.com/acroposthion_019.htm | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb | }}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb | ||
| quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences. | |quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences. | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=SkinMedica | |publisher=SkinMedica | ||
| | |date=2002-02-12 | ||
| title=SkinMedica Introduces TNS Recovery Complex | |title=SkinMedica Introduces TNS Recovery Complex | ||
| url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex | |url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> | }}</ref> | ||
| Line 32: | Line 32: | ||
Dermagraft-TC is FDA approved,<ref>{{REFweb | Dermagraft-TC is FDA approved,<ref>{{REFweb | ||
| quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | |quote=Dermagraft-TC is the first human, fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=MediLexicon International Ltd | |publisher=MediLexicon International Ltd | ||
| date=2011 | |date=2011 | ||
| title=Dermagraft-TC: General Information: Advanced Tissue Sciences | |title=Dermagraft-TC: General Information: Advanced Tissue Sciences | ||
| url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | ||
| accessdate=2011-05-07 | |accessdate=2011-05-07 | ||
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| quote=the Food and Drug Administration has approved Dermagraft-TC | |quote=the Food and Drug Administration has approved Dermagraft-TC | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=HighBeam Research | |publisher=HighBeam Research | ||
| date=1997-03-28 | |date=1997-03-28 | ||
| title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | |title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | ||
| url=http://www.highbeam.com/doc/1G1-47248437.html | |url=http://www.highbeam.com/doc/1G1-47248437.html | ||
| accessdate=2011-05-07 | |accessdate=2011-05-07 | ||
}}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> | }}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> | ||
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.<ref>{{REFbook | Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.<ref>{{REFbook | ||
|last=Pitta | |last=Pitta | ||
|first=Julie | |first=Julie | ||
|init=J | |||
|date=1993-05-10 | |date=1993-05-10 | ||
|title=Biosynthetics | |title=Biosynthetics | ||
| Line 61: | Line 62: | ||
|volume= | |volume= | ||
|chapter= | |chapter= | ||
|pages=170- | |pages=170-1 | ||
|location= | |location= | ||
|publisher=Forbes | |publisher=Forbes | ||
| Line 69: | Line 70: | ||
}}</ref> | }}</ref> | ||
In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.<ref>Biotech's Big Discovery | In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.<ref>{{REFjournal | ||
|title=Biotech's Big Discovery | |||
|last=Hall | |||
|init=CT | |||
|journal=San Francisco Chronicle | |||
|date=1996-10-25 | |||
|pages=E1+E4 | |||
}}</ref> | |||
{{SEEALSO}} | |||
* [[Gail K. Naughton]] | |||
{{REF}} | {{REF}} | ||
| Line 75: | Line 86: | ||
[[Category:Financial gain]] | [[Category:Financial gain]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
[[de:{{FULLPAGENAME}}]] | |||